The incorporation of low-substituted hydroxypropyl cellulose into solid dispersion systems

References

• Lipinski CA. Poor aqueous solubility – an industry wide problem in drug discovery. Am Pharmaceut Rev 2002;5:82–5
   Google Scholar
• Lipinski CA. Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 2000;44:235–49
   PubMed Web of Science ®Google Scholar
• Lipinski CA. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol 2004;1:337–41
   PubMedGoogle Scholar
• Sarkari M, Brown J, Chen X, et al. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int J Pharm 2002;243:17–31
   PubMed Web of Science ®Google Scholar
• Rogers TL, Nelsen AC, Hu J, et al. A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: Spray-freezing into liquid. Eur J Pharm Biopharm 2002;54:271–80
   PubMed Web of Science ®Google Scholar
• Porter CJ, Wasan KM, Constantinides P. Lipid-based systems for the enhanced delivery of poorly water soluble drugs. Adv Drug Deliv Rev 2008;60:615–16
   PubMed Web of Science ®Google Scholar
• Kesisoglou F, Panmai S, Wu Y. Nanosizing – oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev 2007;59:631–44
   PubMed Web of Science ®Google Scholar
• Peltonen L, Hirvonen J. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods. J Pharm Pharmacol 2010;62:1569–79
   PubMed Web of Science ®Google Scholar
• Neslihan Gursoy R, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173–82
   PubMed Web of Science ®Google Scholar
• Gao P, Rush BD, Pfund WP, et al. Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J Pharm Sci 2003;92:2386–98
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
   PubMed Web of Science ®Google Scholar
• Serajuddin ATM. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. J Pharm Sci 1999;88:1058–66
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 2007;12:1068–75
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Hughey JR, Brough C, et al. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm 2010;36:1064–78
   PubMed Web of Science ®Google Scholar
• Miller DA, DiNunzio JC, Yang W, et al. Enhanced in vivo absorption of itraconazole via stabilization of supersaturation following acidic-to-neutral pH transition. Drug Dev Ind Pharm 2008;34:890–902
   PubMed Web of Science ®Google Scholar
• Friesen DT, Shanker R, Crew M, et al. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview. Mol Pharm 2008;5:1003–19
   PubMed Web of Science ®Google Scholar
• Breitenbach J. Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 2002;54:107–17
   PubMed Web of Science ®Google Scholar
• Crowley MM, Zhang F, Repka MA, et al. Pharmaceutical applications of hot-melt extrusion: part I. Drug Dev Ind Pharm 2007;33:909–26
   PubMed Web of Science ®Google Scholar
• Repka MA, Battu SK, Upadhye SB, et al. Pharmaceutical applications of hot-melt extrusion: part II. Drug Dev Ind Pharm 2007;33:1043–57
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Brough C, Miller DA, et al. Fusion processing of itraconazole solid dispersions by KinetiSol® dispersing: a comparative study to hot melt extrusion. J Pharm Sci 2010;99:1239–53
   PubMed Web of Science ®Google Scholar
• Hughey JR, Keen JM, Miller DA, et al. The use of inorganic salts to improve the dissolution characteristics of tablets containing Soluplus®-based solid dispersions. Eur J Pharm Sci 2013;48:758–66
   PubMed Web of Science ®Google Scholar
• Coutant CA, Skibic MJ, Doddridge GD, et al. In vitro monitoring of dissolution of an immediate release tablet by focused beam reflectance measurement. Mol Pharm 2010;7:1508–15
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Schilling SU, Coney AW, et al. Use of highly compressible Ceolus™ microcrystalline cellulose for improved dosage form properties containing a hydrophilic solid dispersion. Drug Dev Ind Pharm 2012;38:180–9
   PubMed Web of Science ®Google Scholar
• Sunada H, Bi Y. Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol 2002;122:188–98
   Web of Science ®Google Scholar
• Fukami J, Yonemochi E, Yoshihashi Y, Terada K. Evaluation of rapidly disintegrating tablets containing glycine and carboxymethylcellulose. Int J Pharm 2006;310:101–9
   PubMed Web of Science ®Google Scholar
• Hughey JR, Keen JM, Miller DA, et al. Preparation and characterization of fusion processed solid dispersions containing a viscous thermally labile polymeric carrier. Int J Pharm 2012;438:11–19
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Brough C, Miller DA, et al. Applications of KinetiSol® Dispersing for the production of plasticizer free amorphous solid dispersions. Eur J Pharm Sci 2010;40:179–87
   PubMed Web of Science ®Google Scholar
• Hughey JR, DiNunzio JC, Bennett RC, et al. Dissolution enhancement of a drug exhibiting thermal and acidic decomposition characteristics by fusion processing: a comparative study of hot melt extrusion and KinetiSol® dispersing. AAPS PharmSciTech 2010;11:760–74
   PubMed Web of Science ®Google Scholar
• Tanno F, Nishiyama Y, Kokubo H, Obara S. Evaluation of hypromellose acetate succinate (HPMCAS) as a carrier in solid dispersions. Drug Dev Ind Pharm 2004;30:9–17
   PubMed Web of Science ®Google Scholar